Skip to main content
. 2019 Oct 30;24(6):629–643. doi: 10.1016/j.rpor.2019.09.002

Fig. 1.

Fig. 1

Cumulative risks of coronary artery disease (CAD) as the first cardiac event among 5-year survivors of Hodgkin Lymphoma by time since initial Hodgkin Lymphoma treatment by categories of Heart-Dmean. The estimated 25-year cumulative CAD incidence was 4.1%, 9.4% and 12.6% for patients with a Heart-Dmean of 0 Gy, 15 Gy and ≥25 Gy, respectively. Reprinted with permission. © (2016) American Society of Clinical Oncology. All rights reserved. Van Nimwegen et al.: J Clin Oncol Vol. 34 (3), Year: 2016, 235–43.